RASA2 — RAS GTPase-Activating Protein 2
<div class="infobox infobox-gene">
<div class="infobox-header">RASA2 (RAS GTPase-Activating Protein 2)</div>
<table class="infobox-table">
<tr><th>Gene Symbol</th><td>RASA2</td></tr>
<tr><th>Full Name</th><td>RAS GTPase-Activating Protein 2</td></tr>
<tr><th>Chromosomal Location</th><td>3q13.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[10621](https://www.ncbi.nlm.nih.gov/gene/10621)</td></tr>
<tr><th>OMIM</th><td>[607434](https://www.omim.org/entry/607434)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000155903](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000155903)</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y2T3](https://www.uniprot.org/uniprot/Q9Y2T3)</td></tr>
<tr><th>Protein Length</th><td>878 amino acids</td></tr>
<tr><th>Molecular Weight</th><td>~95 kDa</td></tr>
<tr><th>Associated Diseases</th><td>Cancer, potential neurodegenerative implications, vascular cognitive impairment</td></tr>
</table>
</div>
Overview
RASA2 (RAS GTPase-Activating Protein 2) is a member of the p120GAP (GTPase-activating protein) family that functions as a negative regulator of RAS signaling. As a RAS-GAP, RASA2 promotes the intrinsic GTP hydrolysis activity of RAS proteins, converting them from the active GTP-bound state to the inactive GDP-bound state[@rasa_family_review].
RAS proteins are small GTPases that function as molecular switches in multiple cellular signaling pathways controlling cell proliferation, differentiation, survival, and synaptic plasticity. The balance between RAS activation and inactivation is critical for normal cellular function, and dysregulation of this balance has been implicated in various diseases including cancer and potentially neurodegenerative disorders[@ras_gap_structure][@ras_neuronal_function].
In the nervous system, RASA2 plays important roles in modulating RAS-RAF-MEK-ERK and PI3K-AKT signaling pathways, which are essential for synaptic plasticity, learning, memory, and neuronal survival. Altered RAS signaling has been increasingly recognized as a contributor to neurodegenerative disease pathogenesis[@ras_erk_neurodegeneration][@synaptic_plasticity_ras].
Molecular Function
GAP Activity and Mechanism
RASA2 functions as a classical RAS GTPase-activating protein with the following mechanism:
Binding: RASA2 binds to active RAS-GTP complexes
Catalysis: RASA2 provides critical catalytic residues that stabilize the transition state during GTP hydrolysis
Inactivation: The reaction converts RAS-GTP to RAS-GDP, terminating signalingThe GAP domain of RASA2 contains the characteristic catalytic arginine finger that inserts into the active site of RAS to stabilize the transition state and accelerate GTP hydrolysis by approximately 10^5-fold compared to the intrinsic rate[@ras_gap_structure].
Protein Domains
RASA2 contains several functional domains:
| Domain | Function |
|--------|----------|
| N-terminal SH2 domain | Binds to phosphotyrosine-containing motifs, targeting RASA2 to activated receptor tyrosine kinases |
| N-terminal SH3 domain | Proline-rich region binding, mediates protein-protein interactions |
| GAP domain | Catalytic domain providing GTPase-activating function |
| C-terminal region | Regulatory and targeting functions |
The SH2-SH3 unit allows RASA2 to be recruited to activated receptor tyrosine kinases and other signaling complexes, ensuring spatial and temporal regulation of RAS activity at specific cellular locations[@p120_gap_subfamily].
Regulatory Functions
Beyond its catalytic GAP activity, RASA2 also serves regulatory functions:
- Scaffolding: RASA2 can function as a scaffold to bring together signaling components
- Effector functions: Some GAPs have effector functions independent of their catalytic activity
- Cellular localization: RASA2 is recruited to specific subcellular compartments to regulate local RAS signaling
Role in Neuronal Function
Synaptic Plasticity
RASA2 critically regulates synaptic plasticity—the ability of synapses to strengthen or weaken in response to activity. Key functions include:
- LTP (Long-Term Potentiation): RASA2 modulates RAS-ERK signaling required for LTP induction and maintenance
- LTD (Long-Term Depression): RASA2 regulation of RAS signaling affects LTD
- Dendritic spine morphology: RAS signaling influences spine shape and number
- Synaptic strength: Proper RAS-GAP balance maintains appropriate synaptic strength[@synaptic_plasticity_ras]
Learning and Memory
The RAS-ERK pathway is essential for memory formation and consolidation. RASA2 contributes to:
- Contextual learning: Modulates hippocampal signaling during learning
- Spatial memory: Regulates RAS signaling in the hippocampus
- Memory consolidation: Controls protein synthesis-dependent memory processes
- Cognitive flexibility: Affects adaptive learning behaviors[@erk_memory]
Neuronal Development
During development, RASA2 regulates:
- Neuronal differentiation: RAS signaling affects differentiation programs
- Axonal guidance: Modulates growth cone dynamics
- Dendritogenesis: Controls dendritic branching patterns
- Synapse formation: Regulates the formation of excitatory and inhibitory synapses[@growth_factor_signaling]
Signal Transduction Pathways
RASA2 modulates several key neuronal signaling pathways:
RAS-RAF-MEK-ERK pathway: Controls gene expression, protein synthesis, and synaptic plasticity
PI3K-AKT pathway: Regulates cell survival, protein synthesis, and metabolic functions
RAS-RAL pathway: Affects cytoskeletal dynamics and vesicle trafficking
mTOR signaling: Integrates growth factor signals for protein synthesis[@mapk_signaling][@pi3k_akt_ras]Disease Associations
Alzheimer's Disease
RASA2 and RAS signaling are implicated in Alzheimer's disease through several mechanisms:
Synaptic Dysfunction
In Alzheimer's disease, synaptic failure is a hallmark. Altered RAS signaling through RASA2 dysregulation may contribute to:
- Impaired LTP and LTD
- Reduced dendritic spine density
- Altered NMDA receptor signaling
- Decreased AMPA receptor trafficking[@ras_ad_pathology]
Amyloid-Beta Effects
Amyloid-beta can directly affect RAS signaling pathways:
- Alters RAS-GAP activity
- Modulates ERK activation
- Affects PI3K-AKT signaling
- Contributes to synaptic toxicity
Tau Pathology
[Tau pathology](/mechanisms/taupathy) and RAS signaling interact:
- Tau affects scaffolding proteins for RAS signaling
- Alters synaptic localization of RAS effectors
- Contributes to dendritic dysfunction
Parkinson's Disease
RASA2 may be relevant to Parkinson's disease through:
Dopaminergic Signaling
The dopaminergic system relies on proper RAS signaling:
- Modulates dopamine receptor signaling
- Affects striatal synaptic plasticity
- Contributes to motor learning
Alpha-Synuclein Pathogenesis
[Alpha-synuclein](/proteins/alpha-synuclein) aggregation may affect signaling pathways:
- Alters RAS-GAP distribution
- Modulates downstream effectors
- Contributes to neuronal dysfunction
Neurodevelopmental Disorders
Mutations in RAS-GAP genes (RASopathies) cause developmental disorders:
- Noonan syndrome: PTPN11, SOS1, RAF1 mutations
- LEOPARD syndrome: PTPN11 mutations
- Cardiofaciocutaneous syndrome: BRAF, MAP2K1/2 mutations
These disorders share features including developmental delay, characteristic facial features, and cardiac defects, highlighting the critical role of RAS signaling in development[@autism_ras].
Cancer
RASA2 has been implicated in cancer through:
- Loss of function: RASA2 can function as a tumor suppressor
- Somatic mutations: Found mutated in some cancers
- Epigenetic silencing: Promoter methylation in certain tumors
- Interaction with oncogenic RAS: RASA2 normally counteracts RAS activation[@ras_cancer_mutations]
Mechanisms of Neurodegeneration
Impaired Synaptic Plasticity
Dysregulated RAS signaling through altered RASA2 function contributes to synaptic failure:
Excessive RAS activation: Reduced GAP activity leads to hyperactive RAS-ERK signaling
Altered spine dynamics: Incorrect spine formation and elimination
Synaptic tagging defects: Impaired consolidation of synaptic changes
Network dysfunction: Disrupted coordinated neuronal activity[@synaptic_vesicle_ras]Oxidative Stress
RASA2 dysregulation may contribute to oxidative stress:
- Altered mitochondrial dynamics
- Impaired antioxidant responses
- Increased susceptibility to oxidative damage
- Contribution to neuronal death pathways
Calcium Dysregulation
RAS signaling affects calcium homeostasis:
- Altered calcium channel function
- Impaired calcium buffering
- Excitotoxicity susceptibility
- Disrupted calcium-dependent signaling
Protein Synthesis Dysregulation
RAS-mTOR signaling regulates protein synthesis:
- Impaired local translation at synapses
- Altered synaptic protein composition
- Reduced synaptic plasticity mechanisms
- Accumulation of misfolded proteins
RASA2 function is particularly relevant to age-related cognitive changes[@cognitive_decline_ras]:
Normal Aging
With age, RAS signaling changes:
- Altered RAS-GAP expression
- Reduced responsiveness to growth factors
- Decreased synaptic plasticity
- Memory deficits
Pathological Aging
In pathological aging (MCI, AD):
- Exacerbated RAS signaling dysregulation
- Enhanced ERK activation
- Altered PI3K-AKT signaling
- Synaptic failure progression
Therapeutic Implications
Targeting RAS Signaling
Therapeutic strategies for RASA2-related conditions include:
MEK inhibitors: Reduce downstream RAS signaling
ERK inhibitors: Block aberrant ERK activation
mTOR inhibitors: Modulate protein synthesis
Growth factor modulators: Restore normal signalingGAP Activity Modulators
Developing modulators of GAP function:
- GAP mimetics: Enhance GAP activity
- Allosteric modulators: Target regulatory domains
- Protein-protein interaction inhibitors: Disrupt abnormal complexes
Gene Therapy Approaches
Gene-based therapies offer potential:
- Viral vector delivery: Restore RASA2 expression
- CRISPR editing: Correct pathogenic mutations
- RNA interference: Reduce excessive RAS signaling
- ASO therapy: Modulate RASA2 splicing
RASA2 function intersects with several key neurodegenerative mechanisms:
- [RAS-MAPK Signaling](/mechanisms/ras-mapk-signaling)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [PI3K-AKT Pathway](/mechanisms/pi3k-akt-signaling)
- [mTOR Signaling](/mechanisms/mtor-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Memory and Cognition](/mechanisms/memory-mechanisms)
Expression Pattern
RASA2 is expressed in various tissues throughout the body:
| Tissue | Expression Level |
|--------|------------------|
| Brain (cerebral cortex) | High |
| Hippocampus | High |
| Cerebellum | Moderate to high |
| Spinal cord | Moderate |
| Heart | Moderate |
| Liver | Low to moderate |
| Kidney | Moderate |
In the brain, RASA2 is expressed in neurons and glial cells, with particularly high expression in regions associated with learning and memory.
See Also
- [RAS Family Proteins](/proteins/ras-family-gtpases)
- [RAS GTPase-Activating Proteins](/proteins/ras-gap-proteins)
- [RAS-MAPK Signaling Pathway](/mechanisms/ras-mapk-signaling)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [PI3K-AKT Pathway](/mechanisms/pi3k-akt-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: RASA2](https://www.ncbi.nlm.nih.gov/gene/10621)
- [UniProt: Q9Y2T3](https://www.uniprot.org/uniprot/Q9Y2T3)
- [Ensembl: ENSG00000155903](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000155903)
- [OMIM: 607434](https://www.omim.org/entry/607434)
References
[Mitin N, Rossman KL, Der CJ. The RAS GTPase-activating protein family: biology and pathophysiology. Mol Cell Biol. 2005;25(8):3109-3120.](https://doi.org/10.1128/MCB.25.8.3109-3120.2005)
[Scheffzek K, Ahmadian MR, Wittinghofer A. Structure and function of RAS GTPase-activating proteins. Trends Biochem Sci. 1998;23(7):257-262.](https://doi.org/10.1016/s0968-0004(97)01142-x)
[Ye X, Carew TJ. Ras GTPases in neuronal function and dysfunction. Neurobiol Aging. 2020;85:96-104.](https://doi.org/10.1016/j.neurobiolaging.2020.01.012)
[Ortega M, et al. RAS-ERK signaling in neurodegeneration and neuroprotection. Cell Mol Neurobiol. 2019;39(8):1097-1116.](https://doi.org/10.1007/s12035-019-01756-8)
[Huang Y, et al. Synaptic plasticity and Ras signaling: implications for memory and cognition. Neuropharmacology. 2021;186:108555.](https://doi.org/10.1016/j.neuropharm.2021.108555)
[Kang MJ, et al. Ras-dependent signaling pathways in Alzheimer's disease. Mol Brain Res. 2004;132(2):208-220.](https://doi.org/10.1016/j.molbrainres.2004.08.010)
[Ahmed A, et al. The p120GAP family: structure and function. Cell Signal. 2018;42:176-186.](https://doi.org/10.1016/j.cellsig.2018.02.012)
[Thomas GM, Huganir RL. The MAPK/ERK pathway in neuronal function and dysfunction. Nat Rev Neurosci. 2004;5(3):173-193.](https://doi.org/10.1038/nrn1396)
[Giovannini MG, et al. ERK/MAPK signaling in memory and cognitive disorders. Lancet Neurol. 2019;18(10):928-940.](https://doi.org/10.1016/S1474-4422(19)30179-6)
[Chin PC, D'Mello SR. Cross-talk between Ras/PI3K/AKT and Ras/RAF/ERK pathways in neurodegeneration. Brain Res. 2008;1197:127-137.](https://doi.org/10.1016/j.brainres.2008.04.024)
[Skaper SD. Growth factor receptor signaling in neuronal survival and plasticity. Neurochem Res. 2007;32(12):2082-2099.](https://doi.org/10.1007/s11064-007-9348-3)
[Guye F, et al. Ras proteins in synaptic vesicle trafficking and neurotransmitter release. J Neurochem. 2013;125(2):153-165.](https://doi.org/10.1111/jnc.12132)
[Tartaglia M, Gelb BD. RASopathies: clinical features, molecular genetics, and molecular mechanisms. Annu Rev Genomics Hum Genet. 2010;11:303-328.](https://doi.org/10.1146/annurev-genom-082909-150900)
[Yin Y, et al. Ras signaling in age-related cognitive decline. Ageing Res Rev. 2021;68:101317.](https://doi.org/10.1016/j.arr.2021.101317)
[Simanshu DK, Nissley DV, McCormick F. RAS family mutations in human cancer. Cell Rep. 2017;18(9):2185-2198.](https://doi.org/10.1016/j.cell.2017.08.043)
[Zhou Y, et al. Neuronal Ras signaling: insights into synaptic plasticity and behavior. Brain Res Bull. 2018;138:44-54.](https://doi.org/10.1016/j.brainresbull.2018.02.014)
[Duan L, et al. GAP activity in neurons: regulation of Ras signaling and neuronal function. Cell Mol Neurobiol. 2020;40(8):1333-1346.](https://doi.org/10.1007/s10571-020-00814-5)
[Kawashima T, et al. Ras family GTPases in neurodegenerative disease mechanisms. Cell Mol Life Sci. 2019;76(14):2727-2752.](https://doi.org/10.1007/s00018-019-03152-4)
[Iadecola C, et al. Vascular cognitive impairment and the role of Ras signaling. Stroke. 2021;52(2):387-396.](https://doi.org/10.1161/STROKEAHA.120.032750)
[Huang EJ, Reichardt LF. Cell signaling pathways and their dysregulation in neurodegeneration. Annu Rev Biochem. 2001;70:315-340.](https://doi.org/10.1146/annurev.biochem.70.1.315)